格隆汇1月12日丨生物制药商Immuron(IMRN.US)盘前涨12.21%报2.94美元。公司已获得美国国防部为该公司旗下Travelan药品提供的资助,这一举措是为了研究口服免疫疗法的给药方案,以供美国军队使用。Immuron是一家处于临床阶段的医疗公司,专注于一种新型特异性... 网页链接
$Immuron(IMRN)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-04-11 AccNo: 0001615774-19-005623 Size: 47 KB 网页链接
$Immuron(IMRN)$ RW - Registration Withdrawal Request Filed: 2019-04-08 AccNo: 0001615774-19-005428 Size: 7 KB 网页链接
$Immuron(IMRN)$ 6-K/A [Amend] - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-04-08 AccNo: 0001615774-19-005432 Size: 441 KB 网页链接
$Immuron(IMRN)$ F-3 - Registration statement by foreign private issuers Filed: 2019-04-08 AccNo: 0001615774-19-005438 Size: 393 KB 网页链接
$Immuron(IMRN)$ F-3 - Registration statement by foreign private issuers Filed: 2019-04-01 AccNo: 0001615774-19-005032 Size: 408 KB 网页链接
$Immuron(IMRN)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-03-19 AccNo: 0001615774-19-004182 Size: 80 KB 网页链接
$Immuron(IMRN)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-02-28 AccNo: 0001615774-19-003249 Size: 656 KB 网页链接
$Immuron(IMRN)$ EFFECT - Notice of Effectiveness Filed: 2019-02-11 AccNo: 9999999995-19-000148 Size: 1 KB 网页链接
$Immuron(IMRN)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-29 AccNo: 0000902664-19-000473 Size: 53 KB 网页链接
$Immuron(IMRN)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-01-29 AccNo: 0001615774-19-001183 Size: 59 KB 网页链接